The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.

T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhinan Jin, Lucas K Smith, Vivek K Rajwanshi, Baek Kim, Jerome Deval
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d142108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b678aabdaccf4ba8b5c1a3f06d142108
record_format dspace
spelling oai:doaj.org-article:b678aabdaccf4ba8b5c1a3f06d1421082021-11-18T07:37:56ZThe ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.1932-620310.1371/journal.pone.0068347https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d1421082013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23874596/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact molecular interaction with the polymerase of influenza A virus (IAVpol) has not been elucidated. Here, we developed a biochemical assay to measure the kinetics of nucleotide incorporation by IAVpol in the elongation mode. In this assay, T-705 RTP was recognized by IAVpol as an efficient substrate for incorporation to the RNA both as a guanosine and an adenosine analog. Compared to natural GTP and ATP, the discrimination of T-705 RTP was about 19- and 30-fold, respectively. Although the single incorporation of the ribonucleotide monophosphate form of T-705 did not efficiently block RNA synthesis, two consecutive incorporation events prevented further primer extension. In comparison, 3'-deoxy GTP caused immediate chain termination but was incorporated less efficiently by the enzyme, with a discrimination of 4,900-fold relative to natural GTP. Collectively, these results provide the first detailed biochemical characterization to evaluate the substrate efficiency and the inhibition potency of nucleotide analogs against influenza virus polymerase. The combination of ambiguous base-pairing with low discrimination of T-705 RTP provides a mechanistic basis for the in vitro mutagenic effect of T-705 towards influenza virus.Zhinan JinLucas K SmithVivek K RajwanshiBaek KimJerome DevalPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 7, p e68347 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Zhinan Jin
Lucas K Smith
Vivek K Rajwanshi
Baek Kim
Jerome Deval
The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
description T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical development for the treatment of influenza virus infection. Although it is believed that T-705 potency is mediated by its ribofuranosyl triphosphate (T-705 RTP) metabolite that could be mutagenic, the exact molecular interaction with the polymerase of influenza A virus (IAVpol) has not been elucidated. Here, we developed a biochemical assay to measure the kinetics of nucleotide incorporation by IAVpol in the elongation mode. In this assay, T-705 RTP was recognized by IAVpol as an efficient substrate for incorporation to the RNA both as a guanosine and an adenosine analog. Compared to natural GTP and ATP, the discrimination of T-705 RTP was about 19- and 30-fold, respectively. Although the single incorporation of the ribonucleotide monophosphate form of T-705 did not efficiently block RNA synthesis, two consecutive incorporation events prevented further primer extension. In comparison, 3'-deoxy GTP caused immediate chain termination but was incorporated less efficiently by the enzyme, with a discrimination of 4,900-fold relative to natural GTP. Collectively, these results provide the first detailed biochemical characterization to evaluate the substrate efficiency and the inhibition potency of nucleotide analogs against influenza virus polymerase. The combination of ambiguous base-pairing with low discrimination of T-705 RTP provides a mechanistic basis for the in vitro mutagenic effect of T-705 towards influenza virus.
format article
author Zhinan Jin
Lucas K Smith
Vivek K Rajwanshi
Baek Kim
Jerome Deval
author_facet Zhinan Jin
Lucas K Smith
Vivek K Rajwanshi
Baek Kim
Jerome Deval
author_sort Zhinan Jin
title The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
title_short The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
title_full The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
title_fullStr The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
title_full_unstemmed The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
title_sort ambiguous base-pairing and high substrate efficiency of t-705 (favipiravir) ribofuranosyl 5'-triphosphate towards influenza a virus polymerase.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/b678aabdaccf4ba8b5c1a3f06d142108
work_keys_str_mv AT zhinanjin theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT lucasksmith theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT vivekkrajwanshi theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT baekkim theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT jeromedeval theambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT zhinanjin ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT lucasksmith ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT vivekkrajwanshi ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT baekkim ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
AT jeromedeval ambiguousbasepairingandhighsubstrateefficiencyoft705favipiravirribofuranosyl5triphosphatetowardsinfluenzaaviruspolymerase
_version_ 1718423185641177088